e.g. Filippa Pettersson or Cancer Res. 75(6) , 1102-12, (2015) or 10.1002/anie.201600521
Discovery of 1-[2-(2, 4-dimethylphenylsulfanyl) phenyl] piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder
The synthesis and structure− activity relationship of a novel series of compounds with combined effects on 5-HT3A and 5-HT1A receptors and on the serotonin (5-HT) transporter (SERT) are described. Compound 5m (Lu AA21004) was the lead compound, displaying high affinity for recombinant human 5-HT1A (K i= 15 nM), 5-HT1B (K i= 33 nM), 5-HT3A (K i= 3.7 nM), 5-HT7 (K i= 19 nM), and noradrenergic β1 (K i= 46 nM) receptors, and SERT (K i= ...